Miliary tuberculosis after biological therapy for rheumatoid arthritis

被引：12

作者：

Querini, PR ^{[1
]}

Vecellio, M ^{[1
]}

Sabbadini, MG ^{[1
]}

Ciboddo, G ^{[1
]}

机构：

[1] San Raffaele Univ Hosp, Clin Immunol & Rheumatol Unit, Dept Internal Med, I-20132 Milan, Italy

来源：

RHEUMATOLOGY | 2002年 / 41卷 / 02期

关键词：

D O I：

10.1093/rheumatology/41.2.231

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：231A / 231A

页数：1

共 4 条

[1]

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [J].

Bathon, JM ;

Martin, RW ;

Fleischmann, RM ;

Tesser, JR ;

Schiff, MH ;

Keystone, EC ;

Genovese, MC ;

Wasko, MC ;

Moreland, LW ;

Weaver, AL ;

Markenson, J ;

Finck, BK .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1586-1593

[2]

Kaufmann SHE, 1998, CHEM IMMUNOL, V70, P21

[3]

Biologic therapy for rheumatoid arthritis [J].

Klippel, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1640-1641

[4]

Infliximab and methotrexate in the treatment of rheumatoid arthritis [J].

Lipsky, PE ;

van der Heijde, DMFM ;

St Clair, EW ;

Furst, DE ;

Breedveld, FC ;

Kalden, JR ;

Smolen, JS ;

Weisman, M ;

Emery, P ;

Feldmann, M ;

Harriman, GR ;

Maini, RN .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1594-1602

← 1 →